Ogilvie syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{Infobox_Disease | | {{Infobox_Disease | | ||
| Line 15: | Line 16: | ||
}} | }} | ||
{{Ogilvie syndrome}} | {{Ogilvie syndrome}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AEL}} | ||
{{SK}} Colonic pseudoobstruction | {{SK}} Colonic pseudoobstruction | ||
Latest revision as of 06:30, 20 October 2020
For patient information click here
| Ogilvie syndrome | |
| ICD-9 | 560.89 |
|---|---|
| DiseasesDB | 10868 |
| Ogilvie syndrome Microchapters
|
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ogilvie syndrome On the Web |
|
American Roentgen Ray Society Images of Ogilvie syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Synonyms and keywords: Colonic pseudoobstruction
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Ogilvie syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies